Mouse Models of Gastrointestinal Tumors

Overview

Journal Cancer Sci

Specialty Oncology

Date 2006 Apr 25

PMID 16630131

Citations 35

Authors

Makoto Mark Taketo

Affiliations

Soon will be listed here.

Abstract

The laboratory mouse (Mus musculus) has become one of the best model animal species in biomedical research today because of its abundant genetic/genomic information, and easy mutagenesis using transgenic and gene knockout technology. Genetically engineered mice have become essential tools in both mechanistic studies and drug development. In this article I will review recent topics in gastrointestinal cancer model mice, with emphasis on the results obtained in our laboratory. They include: (i) mouse models for familial adenomatous polyposis (Apc mutant mice; modifier genes of Apc intestinal polyposis; stabilizing beta-catenin mutant mice); (ii) mouse models for colon cancer (mouse models for hereditary non-polyposis colon cancer; additional mutations in Apc mutant mice; models with mutations in other genes; models for colon cancer associated with inflammatory bowel diseases); and (iii) mouse models for gastric cancer.

Citing Articles

Depletion of transmembrane mucin 4 (Muc4) alters intestinal homeostasis in a genetically engineered mouse model of colorectal cancer.

Pothuraju R, Pai P, Chaudhary S, Siddiqui J, Cox J, Kaur S Aging (Albany NY). 2022; 14(5):2025-2046.

PMID: 35255004 PMC: 8954958. DOI: 10.18632/aging.203935.

Different tumorigenicity and distinct metastasis and gene signature between orthotopic and subcutaneous neuroblastoma xenografted mice.

Han R, Zhao W, Gu X, Gao X, Yang Y, Zhang X Aging (Albany NY). 2022; 14(4):1932-1940.

PMID: 35197367 PMC: 8908914. DOI: 10.18632/aging.203913.

Intestinal Morphogenesis in Development, Regeneration, and Disease: The Potential Utility of Intestinal Organoids for Studying Compartmentalization of the Crypt-Villus Structure.

Kwon O, Han T, Son M Front Cell Dev Biol. 2020; 8:593969.

PMID: 33195268 PMC: 7644937. DOI: 10.3389/fcell.2020.593969.

Characterization and Validation of a Three-Dimensional Multi-Cellular Culture Model to Study Heterotypic Interactions in Colorectal Cancer Cell Growth, Invasion and Metastasis.

Cattin S, Ramont L, Ruegg C Front Bioeng Biotechnol. 2018; 6:97.

PMID: 30065926 PMC: 6056662. DOI: 10.3389/fbioe.2018.00097.

Identification and causes of metabonomic difference between orthotopic and subcutaneous xenograft of pancreatic cancer.

Zhan B, Wen S, Lu J, Shen G, Lin X, Feng J Oncotarget. 2017; 8(37):61264-61281.

PMID: 28977862 PMC: 5617422. DOI: 10.18632/oncotarget.18057.

References

Lickert H, Domon C, Huls G, Wehrle C, Duluc I, Clevers H . Wnt/(beta)-catenin signaling regulates the expression of the homeobox gene Cdx1 in embryonic intestine. Development. 2000; 127(17):3805-13. DOI: 10.1242/dev.127.17.3805. View

Ahn B, Ohshima H . Suppression of intestinal polyposis in Apc(Min/+) mice by inhibiting nitric oxide production. Cancer Res. 2001; 61(23):8357-60. View

DuBois R . New agents for cancer prevention. J Natl Cancer Inst. 2002; 94(23):1732-3. DOI: 10.1093/jnci/94.23.1732. View

Sung J, Leung W, Go M, To K, Cheng A, Ng E . Cyclooxygenase-2 expression in Helicobacter pylori-associated premalignant and malignant gastric lesions. Am J Pathol. 2000; 157(3):729-35. PMC: 1885697. DOI: 10.1016/S0002-9440(10)64586-5. View

Solomon S, McMurray J, Pfeffer M, Wittes J, Fowler R, Finn P . Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. N Engl J Med. 2005; 352(11):1071-80. DOI: 10.1056/NEJMoa050405. View

Yamada T, Mori Y, Hayashi R, Takada M, Ino Y, Naishiro Y . Suppression of intestinal polyposis in Mdr1-deficient ApcMin/+ mice. Cancer Res. 2003; 63(5):895-901. View

Gounari F, Signoretti S, Bronson R, Klein L, Sellers W, Kum J . Stabilization of beta-catenin induces lesions reminiscent of prostatic intraepithelial neoplasia, but terminal squamous transdifferentiation of other secretory epithelia. Oncogene. 2002; 21(26):4099-107. DOI: 10.1038/sj.onc.1205562. View

Luo G, Santoro I, McDaniel L, Nishijima I, Mills M, Youssoufian H . Cancer predisposition caused by elevated mitotic recombination in Bloom mice. Nat Genet. 2000; 26(4):424-9. DOI: 10.1038/82548. View

Su L, Kinzler K, Vogelstein B, Preisinger A, Moser A, Luongo C . Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science. 1992; 256(5057):668-70. DOI: 10.1126/science.1350108. View

10.

Wilson C, Heppner K, Labosky P, Hogan B, Matrisian L . Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin. Proc Natl Acad Sci U S A. 1997; 94(4):1402-7. PMC: 19803. DOI: 10.1073/pnas.94.4.1402. View

11.

de Leng W, Westerman A, Weterman M, de Rooij F, Dekken Hv H, de Goeij A . Cyclooxygenase 2 expression and molecular alterations in Peutz-Jeghers hamartomas and carcinomas. Clin Cancer Res. 2003; 9(8):3065-72. View

12.

Takeda H, Sonoshita M, Oshima H, Sugihara K, Chulada P, Langenbach R . Cooperation of cyclooxygenase 1 and cyclooxygenase 2 in intestinal polyposis. Cancer Res. 2003; 63(16):4872-7. View

13.

Sansom O, Berger J, Bishop S, Hendrich B, Bird A, Clarke A . Deficiency of Mbd2 suppresses intestinal tumorigenesis. Nat Genet. 2003; 34(2):145-7. DOI: 10.1038/ng1155. View

14.

Velcich A, Yang W, Heyer J, Fragale A, Nicholas C, Viani S . Colorectal cancer in mice genetically deficient in the mucin Muc2. Science. 2002; 295(5560):1726-9. DOI: 10.1126/science.1069094. View

15.

Ushijima T, Sasako M . Focus on gastric cancer. Cancer Cell. 2004; 5(2):121-5. DOI: 10.1016/s1535-6108(04)00033-9. View

16.

Correa P . Helicobacter pylori infection and gastric cancer. Cancer Epidemiol Biomarkers Prev. 2003; 12(3):238s-241s. View

17.

Oshima M, Taketo M . COX selectivity and animal models for colon cancer. Curr Pharm Des. 2002; 8(12):1021-34. DOI: 10.2174/1381612023394953. View

18.

Romagnolo B, Berrebi D, Porteu A, Pichard A, Peuchmaur M, Vandewalle A . Intestinal dysplasia and adenoma in transgenic mice after overexpression of an activated beta-catenin. Cancer Res. 1999; 59(16):3875-9. View

19.

Taketo M . Cyclooxygenase-2 inhibitors in tumorigenesis (part I). J Natl Cancer Inst. 1998; 90(20):1529-36. DOI: 10.1093/jnci/90.20.1529. View

20.

Rudolph U, Finegold M, Rich S, Harriman G, Srinivasan Y, Brabet P . Ulcerative colitis and adenocarcinoma of the colon in G alpha i2-deficient mice. Nat Genet. 1995; 10(2):143-50. DOI: 10.1038/ng0695-143. View